Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-795-1 | CAS number: 99-86-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
Data source
Reference
- Reference Type:
- publication
- Title:
- Examination of a -terpinene on Primary Eye Irritancy and Skin Sensitization
- Author:
- Park B.S.
- Year:
- 2 007
- Bibliographic source:
- Mol. Cell. Toxicol. Vol. 3(1), 68-75, 2007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Korean Food and Drug Administration (KFDA) guidelines (98-116)
- Principles of method if other than guideline:
- The experiments were conducted in accordance with the Korean Food and Drug Administration (KFDA) guidelines (98-116). In this study, rabbits were divided into two groups. One group of three rabbits was washed with 20 mL of warmed distilled saline (W group). A second group of six rabbits did not have their eyes flushed with saline (NW group). The eyes or both groups were subsequently examined for indication of ocular and periocular trauma and/or inflammation at 1, 2, 3, 7, 10 and 13 days after treatment.
Eye tissues were sampled by biopsy at 14 days after treatment. Rabbits were sedated with intramuscular xylazine hydrochloride (5 mg/kg) and anesthetized with ketamine hydrochloride (35 mg/kg). Biopsies of the eyes were sampled and fixed in Bouin solution for several days. The eyes then underwent ethanol series dehydration and the tissue was embedded in paraffin. Sections were stained with he-matoxylin-eosin for observation of the cornea, iris and retina.
After treatment, I.I.O.I (the individual index of ocular irritation), M.I.O.I. (Mean index of ocular irritation) and I.A.O.I. (the index of acute ocular irritation) were calculated following a guideline of Korea Institute of Toxicology (Daejeon, Korea). - GLP compliance:
- not specified
Test material
- Reference substance name:
- p-mentha-1,3-diene
- EC Number:
- 202-795-1
- EC Name:
- p-mentha-1,3-diene
- Cas Number:
- 99-86-5
- Molecular formula:
- C10H16
- IUPAC Name:
- 1-isopropyl-4-methylcyclohexa-1,3-diene
- Test material form:
- liquid
- Details on test material:
- Clear colourless liquid.
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source of test material: alpha terpinene purchased from Sigma (St. Louis, MO)
Repellent solution prepared using 0.5 g (2.0%) of alpha terpinene.
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Remarks:
- males and females
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: New Zealand white, Sejin Laboratory Co. (Seoul, South Korea)
- Age at study initiation: 12-18 weeks of age
- Weight at study initiation: male (2.8-3.3 kg) and female (2.7-3.4 kg)
- Acclimation period: yes, for 5 days before testing
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 16-21.6 °C
- Humidity (%): of 40-70%
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12 h photoperiod
Test system
- Vehicle:
- other: Repellent solution
- Controls:
- yes
- Amount / concentration applied:
- Repellent solution (0.1 mL) of 0.5 g (2.0%) of alpha terpinene
- Duration of treatment / exposure:
- Eye tissues were sampled by biopsy at 14 days after treatment.
- Observation period (in vivo):
- 1, 2, 3, 4, 7,10 and 13 days
- Number of animals or in vitro replicates:
- 9 animals (6 animals and 3 animals used as a satellite group of animals to investigate the influence of washing).
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing: yes, performed on one group (W group):
2 groups of animals:
- 3 rabbits were washed with 20 mL of warmed distilled saline (W group)
- 6 other rabbits did not have their eyes flushed with saline (NW group)
- Time after start of exposure: Washed group – 20-30 seconds of treatment following the guideline of Korea Institute of Toxicology (Daejeon, Korea).
SCORING SYSTEM: yes
I.I.O.I (the individual index of ocular irritation), M.I.O.I. (Mean index of ocular irritation) and I.A.O.I. (the index of acute ocular irritation) were calculated following a guideline of Korea Institute of Toxicology (Daejeon, Korea).
TOOL USED TO ASSESS SCORE: Sections of the eyes were stained with he-matoxylin-eosin for observation of the cornea, iris and retina.
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 6
- Remarks:
- non washed group
- Time point:
- other: days 1, 2, 3, 4, 7, 10 and 13
- Score:
- > 1 - < 4
- Max. score:
- 4
- Reversibility:
- fully reversible within: 10 days
- Remarks on result:
- positive indication of irritation
- Irritation parameter:
- iris score
- Remarks:
- redness
- Basis:
- animal: 6
- Remarks:
- non washed group
- Time point:
- other: days 1, 2, 3, 4, 7, 10 and 13
- Score:
- > 1 - < 3
- Max. score:
- 3
- Reversibility:
- fully reversible within: 4 days
- Remarks on result:
- positive indication of irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal: 6
- Remarks:
- non washed group
- Time point:
- other: days 1, 2, 3, 4, 7, 10 and 13
- Score:
- > 1 - < 4
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Remarks on result:
- positive indication of irritation
- Irritation parameter:
- other: Discharge
- Basis:
- animal: 6
- Remarks:
- non washed group
- Time point:
- other: days 1, 2, 3, 4, 7, 10 and 13
- Score:
- > 1 - < 3
- Max. score:
- 3
- Reversibility:
- fully reversible within: 10 days
- Remarks on result:
- positive indication of irritation
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: mean of 6
- Remarks:
- non washed group
- Time point:
- 24/48/72 h
- Score:
- ca. 2
- Reversibility:
- fully reversible
- Remarks on result:
- positive indication of irritation
- Irritation parameter:
- iris score
- Basis:
- animal: mean of 6
- Remarks:
- non washed group
- Time point:
- 24/48/72 h
- Score:
- > 1 - < 2
- Reversibility:
- fully reversible
- Remarks on result:
- positive indication of irritation
- Irritation parameter:
- conjunctivae score
- Basis:
- animal: mean of 6
- Remarks:
- non washed group
- Time point:
- 24/48/72 h
- Score:
- ca. 2
- Reversibility:
- fully reversible
- Remarks on result:
- positive indication of irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal: mean of 6
- Remarks:
- non washed group
- Time point:
- 24/48/72 h
- Score:
- ca. 2
- Reversibility:
- fully reversible
- Remarks on result:
- positive indication of irritation
- Other effects:
- Other observations:
Ocular discharge was collected using pasteurized swabs at 1, 2, 3, 4, 7, 10 and 13 days after treatment. Ocular discharges were smeared on to a glass slide and fixed for 20-30 min using methanol. After fixing, slides were stained with Giemsa solution for 20-25 min. Stained slides were observed under a light
microscope. Cellular components of ocular discharges were determined and numbers of each component were scores.
Any other information on results incl. tables
Table 1. Grading of ocular lesions – Cornea |
|||
OECD TG 405 guideline |
Scoring OECD TG 405 |
KFDA guideline |
Scoring KFDA |
Opacity: degree of density (readings should be taken from most dense area)* |
|
Opacity - Degree of density (area which is most dense is taken for reading) |
|
No ulceration or opacity |
0 |
Normal |
0 |
Scattered or diffuse areas of opacity (other than slight dulling of normal lustre); details of iris clearly visible |
1 |
Scattered or diffuse - details of iris clearly visible |
1 |
Easily discernible translucent area; details of iris slightly obscured |
2 |
Easily discernible translucent areas details of iris slightly obscured |
2 |
Nacrous area; no details of iris visible; size of pupil barely discernible |
3 |
Opalescent areas no details of iris visible, siae of pupilbarely discernible |
3 |
Opaque cornea; iris not discernible through the opacity |
4 |
Opaque. iris invisible |
4 |
|
|
Area of cornea involved |
|
|
|
Zero |
0 |
|
|
One quarter (or less) but not zero |
1 |
|
|
Greater than one-quarter and less than one -half |
2 |
|
|
Greater than one-half and less than three quarters |
3 |
|
|
Greater than three quarters up to whole area |
4 |
* The area of corneal opacity should be noted
Table 2. Grading of ocular lesions – Iris |
|||
OECD TG 405 guideline |
Scoring OECD TG 405 |
KFDA guideline |
Scoring KFDA |
Normal |
0 |
Normal |
0 |
Markedly deepened rugae, congestion, swelling, moderate circumcorneal hyperaemia; or injection; iris reactive to light (a sluggish reaction is considered to be an effect
|
1 |
Folds above normal, congestion, swelling, circumcorneal injection (anyone or all of these or combination of any thereof), iris still reacting to light |
1 |
Hemorrhage, gross destruction, or no reaction to light
|
2 |
No reaction to light, hemorrhage, gross destruction (any one or all of these) |
2 |
Table 3. Grading of ocular lesions – Conjunctivae |
|||
OECD TG 405 guideline |
Scoring OECD TG 405 |
KFDA guideline |
Scoring KFDA |
redness (refers to palpebral and bulbar conjunctivae; excluding cornea and iris) |
|
Redness (refers to palpebral conjuctiva only)
|
|
Normal |
0 |
Normal |
0 |
Some blood vessels hyperaemic (injected) |
1 |
Vessels definitely injected above normal |
1 |
Diffuse, crimson colour; individual vessels not easily discernible
|
2 |
More diffuse deeper crimson red (individual vessels not easily discernible) |
2 |
Diffuse beefy red |
3 |
Diffused beefy red |
3 |
Table 4. Grading of ocular lesions – Chemosis |
|||
OECD TG 405 guideline |
Scoring OECD TG 405 |
KFDA guideline |
Scoring KFDA |
Swelling (refers to lids and/or nictating membranes) |
|
|
|
Normal |
0 |
Normal |
0 |
Some swelling above normal |
1 |
Any swelling above normal (inclused nictitating membrane) |
1 |
Obvious swelling, with partial eversion of lids
|
2 |
Obvious swelling with partial eversion of lids |
2 |
Swelling, with lids about half closed |
3 |
Swelling with lids about half closed |
3 |
Swelling, with lids more than half closed |
4 |
Swelling with lids about half closed to completely closed |
4 |
Table 5. Grading of ocular lesions – Discharge
|
|||
OECD TG 405 guideline |
Scoring OECD TG 405 |
KFDA guideline |
Scoring KFDA |
|
0 |
Normal |
0 |
|
1 |
Any amount different from normal (does not include small amount observed in inner canthus of normal animals) |
1 |
|
2 |
Discharge with moistening of the lids and hairs just adjacent to the lids |
2 |
|
3 |
Discharge with moistening of the lids and considerable area around the eye |
3 |
Table 6.Results of eye reactions – NON-washed group (NW) |
|||
Observation |
Mean Animal No. |
Days |
Mean value of the scoring |
Degree of opacity |
6 |
1 |
2.6 |
|
6 |
2 |
1.6 |
|
6 |
3 |
1.3 |
|
6 |
4 |
0.83 |
|
6 |
7 |
0 |
|
6 |
10 |
0 |
|
6 |
13 |
0 |
Diffuse are of opacity |
6 |
1 |
2.5 |
|
6 |
2 |
2 |
|
6 |
3 |
1.3 |
|
6 |
4 |
0.3 |
|
6 |
7 |
0 |
|
6 |
10 |
0 |
|
6 |
13 |
0 |
Iris |
No change |
||
Conjuctiva - redness |
6 |
1 |
2.3 |
|
6 |
2 |
2.16 |
|
6 |
3 |
1.3 |
|
6 |
4 |
0.3 |
|
6 |
7 |
0.16 |
|
6 |
10 |
0 |
|
6 |
13 |
0 |
Chemosis |
6 |
1 |
2.3 |
|
6 |
2 |
1.5 |
|
6 |
3 |
0.5 |
|
6 |
4 |
0.16 |
|
6 |
7 |
0 |
|
6 |
10 |
0 |
|
6 |
13 |
0 |
Discharge |
6 |
1 |
2.5 |
|
6 |
2 |
2.5 |
|
6 |
3 |
1.83 |
|
6 |
4 |
1.16 |
|
6 |
7 |
0.16 |
|
6 |
10 |
0 |
|
6 |
13 |
0 |
Table 7. Results of eye reactions – washed group (W) |
|||
Observation |
Mean Animal No. |
Days |
Mean value of the scoring |
Degree of opacity |
3 |
1 |
1.3 |
|
3 |
2 |
1 |
|
3 |
3 |
0 |
|
3 |
4 |
0 |
|
3 |
7 |
0 |
|
3 |
10 |
0 |
|
3 |
13 |
0 |
|
3 |
1 |
1.3 |
|
3 |
2 |
1 |
|
3 |
3 |
0 |
|
3 |
4 |
0 |
|
3 |
7 |
0 |
|
3 |
10 |
0 |
|
3 |
13 |
0 |
Iris |
No change |
||
Conjuctiva - redness |
3 |
1 |
1 |
|
3 |
2 |
1 |
|
3 |
3 |
0 |
|
3 |
4 |
0 |
|
3 |
7 |
0 |
|
3 |
10 |
0 |
|
3 |
13 |
0 |
Chemosis |
3 |
1 |
1.3 |
|
3 |
2 |
0.3 |
|
3 |
3 |
0 |
|
3 |
4 |
0 |
|
3 |
7 |
0 |
|
3 |
10 |
0 |
|
3 |
13 |
0 |
Discharge |
3 |
1 |
1.6 |
|
3 |
2 |
1 |
|
3 |
3 |
0 |
|
3 |
4 |
0 |
|
3 |
7 |
0 |
|
3 |
10 |
0 |
|
3 |
13 |
0 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 2 (irritating to eyes) based on GHS criteria
- Conclusions:
- Based on the results of this study, alpha terpinene is classified as irritant cat. 2 according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
- Executive summary:
In the key study of Park (2007), the primary eye irritation test procedure was performed according to the “Guidelines for Toxicity Studies of Drugs” provided by Korea Food and Drug Administration (KFDA). The corneal opacity, iris and conjunctival redness, edemas were recorded and classified according to the guideline of KFDA.
Repellent solution (0.1 mL) of 2.0% of alpha terpinene was dropped in the right eye of nine rabbits. Rabbits were divided into two groups. One group of three rabbits was washed with 20 mL of warmed distilled saline (W group, satellite group of animals to investigate the influence of washing). A second group of six rabbits did not have their eyes flushed with saline (NW group). The eyes or both groups were subsequently examined for indication of ocular and periocular trauma and/or inflammation at 1, 2, 3, 7, 10 and 13 days after treatment.
The application of alpha terpinene to the eye could cause the redness to the conjunctiva. However, the redness disappeared after 3 days in the W group and 7 days in the NW group, with exception of one rabbit that took 10 days. No permanent damage has been observed. Moreover, the redness could easily be prevented with saline washing shortly after any accidental exposure.
Chemosis and discharge of the conjunctiva were observed 1 day after treatment in all tested animals. Most discharge the formation on the treated eyes first one to 3 days after treatment. Similarly to the redness, chemosis and discharge of the conjunctiva eventually disappeared after exposure and could be prevented with saline washing.
Eye tissues were sampled by biopsy at 14 days after treatment. Rabbits were sedated with intramuscular xylazine hydrochloride (5 mg/kg) and anesthetized with ketamine hydrochloride (35 mg/kg). Biopsies of the eyes were sampled and fixed in Bouin for several days. The eyes then underwent ethanol series dehydration and the tissue was embedded in paraffin. Sections were stained with hematoxylin-eosin for observation of the cornea, iris and retina.
The individual index of ocular irritation (I.O.I. score) was calculated as follows:
I.O.I = (Degree of opacity X Diffuse are of opacityX5) + (IrisX5) + 2(Redness+ Chemosis+ Discharge)
Based on the rating system provided on sums of all scores obtained from ocular lesions, it was concluded that alpha terpinene was irritating.
For the purpose of this registration, the scores obtained according to the KFDA guideline were compared to the scoring system of the OECD TG 405 - grading of ocular lesions. The mean grades of ocular reaction (conjunctivae, cornea and iris) recorded after 24, 48 and 72 hours were calculated and the mean score for six animals, non-washed group was approx. 2. Furthermore, the potential eye irritation caused by a 2% solution of alpha terpinene was significantly curtailed by an immediate application of saline solution as demonstrated in the washed group.
Based on these results, alpha terpinene is classified as an eye irritant, cat. 2 according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
